Manavotam Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manavotam Singh has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Hunter Groninger
MedStar Washington Hospital Center, Washington, USA
4 shared publications - Vijaywant Brar
Division of Cardiology, Louisiana State University, Shreveport, Louisiana, USA
4 shared publications - Anirudh Rao
Department of Medicine, MedStar Washington Hospital Center, Washington, DC; Georgetown University School of Medicine, Washington, DC
3 shared publications - Farooq H. Sheikh
MedStar Heart and Vascular Institute, Georgetown University School of Medicine, Washington, DC, USA
3 shared publications Cyrus Hadadi
Division of Cardiology, MedStar Heart and Vascular Institute MedStar Washington Hospital Center Washington District of Columbia USA
2 shared publications- Ezequiel J. Molina
Department of Cardiac Surgery, Piedmont Heart Institute, Atlanta, Georgia, USA
2 shared publications
Latest Publications
- Open Access
- 30 January 2024
- Published by Wiley
Body Piercing with a Metallic Tongue Ring Resulting in Ineffective ICD Shocks: “Heart to Mouth”
Left ventricular assist devices (LVADs) provide circulatory support to patients with severe left ventricular systolic dysfunction. Many such patients have a pre-existing implantable cardioverter defibrillator at the time of their LVAD surgery. LVAD implantation can alter ICD lead parameters including R wave sensing, RV capture threshold, and impedance. These changes can in turn affect the ability of the ICD to successfully treat malignant ventricular arrythmias. In most patients who present with ineffective ICD shocks, the failed shock is assumed to be secondary to the patient’s severe cardiomyopathy. Especially the role of physical examination in such patients is often minimized. In our patient a thorough history and history guided physical examination, led us to the root cause of his failed ICD shocks. Our patient was noted to have a metal tongue ring, which was the likely cause of his ineffective ICD shocks. Our case highlights the importance of a comprehensive history and physical examination.
- 30 January 2024
- Published by Wiley
Open AccessBody Piercing with a Metallic Tongue Ring Resulting in Ineffective ICD Shocks: “Heart to Mouth”
Left ventricular assist devices (LVADs) provide circulatory support to patients with severe left ventricular systolic dysfunction. Many such patients have a pre-existing implantable cardioverter defibrillator at the time of their LVAD surgery. LVAD implantation can alter ICD lead parameters including R wave sensing, RV capture threshold, and impedance. These changes can in turn affect the ability of the ICD to successfully treat malignant ventricular arrythmias. In most patients who present with ineffective ICD shocks, the failed shock is assumed to be secondary to the patient’s severe cardiomyopathy. Especially the role of physical examination in such patients is often minimized. In our patient a thorough history and history guided physical examination, led us to the root cause of his failed ICD shocks. Our patient was noted to have a metal tongue ring, which was the likely cause of his ineffective ICD shocks. Our case highlights the importance of a comprehensive history and physical examination.
- 8 August 2022
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 40, 49
Comparison of Patterns of Coronary Artery Disease in Patients With Heart Failure by Cardiac Sarcoidosis Status
- 8 August 2022
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 40, 49
Comparison of Patterns of Coronary Artery Disease in Patients With Heart Failure by Cardiac Sarcoidosis Status
- Open Access
- 15 July 2022
- Published by Texas Heart Institute Journal in Texas Heart Institute Journal
- Vol. 49 (4)
Nontuberculous Mycobacterial Infections Associated With Left Ventricular Assist Devices in 3 Patients
Durable left ventricular assist devices (LVADs) provide circulatory support in patients with end-stage heart failure; however, complications include infection of the driveline exit site. Nontuberculous mycobacterial infections are rare in patients with LVADs, but they should be considered in those who have undergone device exchanges and have bacterial infections with driveline exit-site discharge but no fever or leukocytosis. We reviewed the charts of patients who had an LVAD implanted at our institution from January 2009 through December 2019, to identify those with a device-related nontuberculous mycobacterial infection. Collected data included patient demographics, premorbid conditions, infection type, previous device complications, treatment, and outcomes. We identified infections in 3 patients (mean age, 41 yr): Mycobacterium abscessus in 2 and M. chimaera in 1. All had a HeartMate II device and had undergone device exchanges for pump thrombosis or for driveline fault or infections. All presented with driveline exit-site discharge without fever or leukocytosis. The mean time between initial device implantation and diagnosis of a nontuberculous mycobacterial infection was 55 months. All 3 patients were treated with antibiotics and underwent localized surgical débridement; one underwent an additional device exchange. The M. abscessus infections disseminated, and both patients died; the patient with M. chimaera infection continued to take suppressive antibiotics. Nontuberculous mycobacterial infections are associated with high morbidity and mortality rates, warranting prompt diagnosis and treatment.
- 15 July 2022
- Published by Texas Heart Institute Journal in Texas Heart Institute Journal
- Vol. 49 (4)
Open AccessNontuberculous Mycobacterial Infections Associated With Left Ventricular Assist Devices in 3 Patients
Durable left ventricular assist devices (LVADs) provide circulatory support in patients with end-stage heart failure; however, complications include infection of the driveline exit site. Nontuberculous mycobacterial infections are rare in patients with LVADs, but they should be considered in those who have undergone device exchanges and have bacterial infections with driveline exit-site discharge but no fever or leukocytosis. We reviewed the charts of patients who had an LVAD implanted at our institution from January 2009 through December 2019, to identify those with a device-related nontuberculous mycobacterial infection. Collected data included patient demographics, premorbid conditions, infection type, previous device complications, treatment, and outcomes. We identified infections in 3 patients (mean age, 41 yr): Mycobacterium abscessus in 2 and M. chimaera in 1. All had a HeartMate II device and had undergone device exchanges for pump thrombosis or for driveline fault or infections. All presented with driveline exit-site discharge without fever or leukocytosis. The mean time between initial device implantation and diagnosis of a nontuberculous mycobacterial infection was 55 months. All 3 patients were treated with antibiotics and underwent localized surgical débridement; one underwent an additional device exchange. The M. abscessus infections disseminated, and both patients died; the patient with M. chimaera infection continued to take suppressive antibiotics. Nontuberculous mycobacterial infections are associated with high morbidity and mortality rates, warranting prompt diagnosis and treatment.
- 28 April 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (5) , S24-S25
Effect Of Tricuspid Regurgitation On Decongestion And Right Atrial Pressure Changes In Patients With Decompensated Heart Failure
- 28 April 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (5) , S24-S25
Effect Of Tricuspid Regurgitation On Decongestion And Right Atrial Pressure Changes In Patients With Decompensated Heart Failure
- 28 April 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (5) , S62
Can We Make The In-Hospital LVAD Deactivation Process At End-of-life Comfortable?
- 28 April 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (5) , S62
Can We Make The In-Hospital LVAD Deactivation Process At End-of-life Comfortable?
- 18 January 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (11) , 1339-1345
In-Hospital Left Ventricular Assist Devices Deactivation and Death Experience: A Single-Institution Retrospective Analysis
Best practices for left ventricular assist devices (LVADs) deactivation at end-of-life (EOL) have yet to be elucidated. We conducted a single-institution retrospective review of patients who died following LVAD deactivation between January 2017 and March 2020. Data were obtained from institutional databases and electronic health record and were analyzed using descriptive statistics. Fifty-eight patients (70% male, 70% African American, median age 62 years) were categorized by implant strategy: bridge therapy (BT, N = 22, 38%) or destination therapy (DT, N = 36, 62%). Clinical events leading to deactivation were categorized either acute (e.g., stroke [N = 31, 53%]), gradual decline (N = 12, 21%), or complications during index hospitalization (N = 15, 26%). Implant strategy was not associated with clinical trajectory leading to EOL (p = 0.67), hospital unit of death (p = 0.13), or use of mechanical ventilation (p = 0.69) or renal replacement therapy (p = 0.81) during terminal hospitalization. Overall time from admission to code status change was mean 27.0 days (SD 30.3 days). Compared with BT patients, DT experienced earlier do-not-resuscitate (DNR) orders (p ≤ 0.01) and shorter survival post-deactivation (p ≤ 0.01). Deactivations after gradual decline tended to occur outside ICUs, compared with acute events or index implant-related complications (p = 0.04). Implant strategy was not associated with differences in EOL experience except regarding timing of DNR order and survival post-deactivation.
- 18 January 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (11) , 1339-1345
In-Hospital Left Ventricular Assist Devices Deactivation and Death Experience: A Single-Institution Retrospective Analysis
Best practices for left ventricular assist devices (LVADs) deactivation at end-of-life (EOL) have yet to be elucidated. We conducted a single-institution retrospective review of patients who died following LVAD deactivation between January 2017 and March 2020. Data were obtained from institutional databases and electronic health record and were analyzed using descriptive statistics. Fifty-eight patients (70% male, 70% African American, median age 62 years) were categorized by implant strategy: bridge therapy (BT, N = 22, 38%) or destination therapy (DT, N = 36, 62%). Clinical events leading to deactivation were categorized either acute (e.g., stroke [N = 31, 53%]), gradual decline (N = 12, 21%), or complications during index hospitalization (N = 15, 26%). Implant strategy was not associated with clinical trajectory leading to EOL (p = 0.67), hospital unit of death (p = 0.13), or use of mechanical ventilation (p = 0.69) or renal replacement therapy (p = 0.81) during terminal hospitalization. Overall time from admission to code status change was mean 27.0 days (SD 30.3 days). Compared with BT patients, DT experienced earlier do-not-resuscitate (DNR) orders (p ≤ 0.01) and shorter survival post-deactivation (p ≤ 0.01). Deactivations after gradual decline tended to occur outside ICUs, compared with acute events or index implant-related complications (p = 0.04). Implant strategy was not associated with differences in EOL experience except regarding timing of DNR order and survival post-deactivation.
- Open Access
- 1 November 2021
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 12 (11) , 4780-4784
Body Piercing with a Metallic Tongue Stud Resulting in Ineffective Implantable Cardioverter-defibrillator Shocks: “Heart to Mouth”
Left ventricular assist devices (LVADs) provide circulatory support to patients with severe left ventricular systolic dysfunction. Many such patients have a pre-existing implantable cardioverter-defibrillator (ICD) at the time of their LVAD surgery. LVAD implantation can alter the ICD lead parameters, including R-wave sensing, right ventricular capture threshold, and impedance. These changes can in turn affect the ability of the ICD to successfully treat malignant ventricular arrhythmias. In most patients who present with ineffective ICD shocks, the failed shock is assumed to be secondary to the patient’s severe cardiomyopathy. Especially, the role of physical examination in such patients is often minimized. In our patient, a thorough history-taking and history-guided physical examination led us to the root cause of the failed ICD shocks. Our patient was noted to have a metal tongue piercing, which was the likely cause of his ineffective ICD shocks. Our case highlights the importance of a comprehensive history-taking and physical examination.
- 1 November 2021
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 12 (11) , 4780-4784
Open AccessBody Piercing with a Metallic Tongue Stud Resulting in Ineffective Implantable Cardioverter-defibrillator Shocks: “Heart to Mouth”
Left ventricular assist devices (LVADs) provide circulatory support to patients with severe left ventricular systolic dysfunction. Many such patients have a pre-existing implantable cardioverter-defibrillator (ICD) at the time of their LVAD surgery. LVAD implantation can alter the ICD lead parameters, including R-wave sensing, right ventricular capture threshold, and impedance. These changes can in turn affect the ability of the ICD to successfully treat malignant ventricular arrhythmias. In most patients who present with ineffective ICD shocks, the failed shock is assumed to be secondary to the patient’s severe cardiomyopathy. Especially, the role of physical examination in such patients is often minimized. In our patient, a thorough history-taking and history-guided physical examination led us to the root cause of the failed ICD shocks. Our patient was noted to have a metal tongue piercing, which was the likely cause of his ineffective ICD shocks. Our case highlights the importance of a comprehensive history-taking and physical examination.
- Open Access
Recurrent Chest Pain After COVID-19: Diagnostic Utility of Cardiac Magnetic Resonance Imaging